InvestorsHub Logo
Followers 58
Posts 10342
Boards Moderated 1
Alias Born 09/21/2016

Re: None

Tuesday, 01/31/2023 9:22:13 AM

Tuesday, January 31, 2023 9:22:13 AM

Post# of 470630

Preclinical studies demonstrated its potential to halt and/or reverse the course of Alzheimer's disease. ANAVEX®2-73 also exhibited anticonvulsant, anti-amnesic, neuroprotective, and anti-depressant properties in animal models, indicating its potential to treat additional CNS disorders, including epilepsy.



We need some RWE-RWD to demo this: ASAP

https://www.anavex.com/post/anavex-life-sciences-to-announce-fiscal-2023-first-quarter-financial-results-on-february-7-2023
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News